Detalhe da pesquisa
1.
Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer.
Br J Cancer
; 130(6): 1036-1045, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267634
2.
Bleeding complications in bcr-abl-negative myeloproliferative neoplasms (MPN): A retrospective single-center study of 829 MPN patients.
Eur J Haematol
; 108(2): 154-162, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34719056
3.
Ruxolitinib-treated polycythemia vera patients and their risk of secondary malignancies.
Ann Hematol
; 100(11): 2707-2716, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462786
4.
Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms.
Hamostaseologie
; 2023 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813367
5.
Metabolic heterogeneity in adrenocortical carcinoma impacts patient outcomes.
JCI Insight
; 8(16)2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606037
6.
Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET.
Hemasphere
; 7(5): e882, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37153877